BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27163153)

  • 1. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
    Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.
    Mauland KK; Trovik J; Wik E; Raeder MB; Njølstad TS; Stefansson IM; Oyan AM; Kalland KH; Bjørge T; Akslen LA; Salvesen HB
    Br J Cancer; 2011 Mar; 104(6):921-6. PubMed ID: 21343929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
    Shi XW; Wang DF; Zhang GN; Zhang J
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.
    Berg HF; Ju Z; Myrvold M; Fasmer KE; Halle MK; Hoivik EA; Westin SN; Trovik J; Haldorsen IS; Mills GB; Krakstad C; Werner HMJ
    Br J Cancer; 2020 Mar; 122(7):1014-1022. PubMed ID: 32037399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between preoperative serum insulin levels and lymph node metastasis in endometrial cancer-a prospective cohort study.
    Mu N; Dong M; Liu C; Wang X; Cong J; Wang L; Wang X; Lakhani I; Liu X; Hou J; Wang S; Tse G
    Cancer Med; 2018 Apr; 7(4):1519-1527. PubMed ID: 29533014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative evaluation and a nomogram prediction model for pelvic lymph node metastasis in endometrial cancer.
    Zhang J; Wang D; Peng L; Shi X; Shi Y; Zhang G
    Eur J Surg Oncol; 2024 Apr; 50(4):108230. PubMed ID: 38430704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
    Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
    Eur Radiol; 2023 Oct; ():. PubMed ID: 37882835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
    Li N; Chen Q; Li B
    Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
    Miller HA; Tran A; LyBarger KS; Frieboes HB
    Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.
    Li H; Wang J; Zhang G; Li L; Shen Z; Zhai Z; Wang Z; Wang J
    Womens Health (Lond); 2024; 20():17455057241248398. PubMed ID: 38725247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
    Dai D; Thiel KW; Salinas EA; Goodheart MJ; Leslie KK; Gonzalez Bosquet J
    Gynecol Oncol; 2016 Jul; 142(1):150-157. PubMed ID: 27181389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting lymph node metastasis in colorectal cancer: An analysis of influencing factors to develop a risk model.
    Lei YP; Song QZ; Liu S; Xie JY; Lv GQ
    World J Gastrointest Surg; 2023 Oct; 15(10):2234-2246. PubMed ID: 37969707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coagulation function indicators and tumor markers on diagnosis and clinicopathological characteristics of endometrial cancer.
    Li H; Liao H; Jing B; Wang Y
    Int J Biol Markers; 2023 Dec; 38(3-4):214-222. PubMed ID: 37635376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
    Zhao Q; Li Y; Wang T
    Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a 3D Resnet Model for Prediction of Lymph Node Metastasis in Head and Neck Cancer Patients.
    Lin YH; Lin CT; Chang YH; Lin YY; Chen JJ; Huang CR; Hsu YW; You WC
    J Imaging Inform Med; 2024 Apr; 37(2):679-687. PubMed ID: 38343258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the Expression of VEGF and Ki67 and Lymph Node Metastasis in Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Wei D; Xin Y; Rong Y; Hao Y
    Evid Based Complement Alternat Med; 2022; 2022():9693746. PubMed ID: 35800006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients.
    Popeda M; Markiewicz A; Stokowy T; Szade J; Niemira M; Kretowski A; Bednarz-Knoll N; Zaczek AJ
    Sci Rep; 2021 Mar; 11(1):5097. PubMed ID: 33658651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Cervicovaginal Cancer Antigen 125 Levels: A Preliminary Study for Endometrial Cancer Screening.
    Calis P; Yuce K; Basaran D; Salman C
    Gynecol Obstet Invest; 2016; 81(6):518-522. PubMed ID: 26871687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.
    Fortner RT; Hüsing A; Kühn T; Konar M; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Severi G; Fournier A; Boeing H; Trichopoulou A; Benetou V; Orfanos P; Masala G; Agnoli C; Mattiello A; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Gram IT; Gavrilyuk O; Quirós JR; Maria Huerta J; Ardanaz E; Larrañaga N; Lujan-Barroso L; Sánchez-Cantalejo E; Butt ST; Borgquist S; Idahl A; Lundin E; Khaw KT; Allen NE; Rinaldi S; Dossus L; Gunter M; Merritt MA; Tzoulaki I; Riboli E; Kaaks R
    Int J Cancer; 2017 Mar; 140(6):1317-1323. PubMed ID: 27935083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.